Actualité

A 4D SCANNER TO “FILM” THE TUMOR

Thanks to a donation of the Stavros Niarchos Foundation, the Center Antoine Lacassagne acquired a 4D scanner, inaugurated on February 23, 2017 at the Mediterranean Institute of Protontherapy.

With this new technology and the Sentinel system, the Mediterranean Institute of Protontherapy can treat patients with “mobile” tumors, that is to say which oscillate with breathing. Indeed, for these tumors, a 4D scanner is necessary to make a “film” of the tumor (4D for 4 dimensions, 3 for space and 1 for time). The medical team can thus precisely identify the displacements of the tumor with the respiration and define precisely the limits to be irradiated. The appreciation of these displacements is more crucial for children for whom the organs are close to each other.

Immediately concerned by this project, the Stavros Niarchos Foudation made it possible, through its donation, to fully finance this new equipment.

Thanks to the implementation of this 4D scanner at the Mediterranean Institute of Protontherapy, the patients, and especially children, can stay in a unit area for their treatment in High Energy Protontherapy. Indeed, for children and their parents coming from other regions of France or from foreign countries, the proximity of the residential care home “La Consolata” allows a simplified circuit: consultations, scanner, treatment and accommodation are proposed on the same area.

Moreover, for young children who require anesthesia for each CT scan and for each treatment, to stay in a unique place reduces the number of anesthesia, facilitates contacts and reduces the stress of children and their families

A 4D SCANNER TO “FILM” THE TUMOR

Actualité

Management of childhood cancers:

A major study was recently published by physicians from Boston in the prestigious Lancet Oncology journal and the “Red Journal” in January 2016. This study shows that a new treatment technique so-called proton therapy reduces immediate and long-term toxicities while maintaining the same efficacy for the child cancer named medulloblastoma.

In this type of disease in order to eradicate cancer cells it is necessary to irradiate the whole brain and spine with the complications that might follow i.e., secondary cancers, cardiac toxicities, hormonal disorders and intellectual disabilities. All of these complications are rare but can be difficult to manage.

Actualité

THE MEDITERRANEAN INSTITUTE TREATS ITS FIRST PATIENT WITH PROTEUS® ONE

Nice, September 19, 2016 – Treatment of the first patient by high-energy protontherapy began at the Mediterranean Institute of Protontherapy, inaugurated on June 30th by the Center Antoine Lacassagne, Nice Cancer Institute, France.

“The first patient benefiting from this innovative technology has a brain tumor which couldn’t be treated by surgery,” explains Dr. Pierre-Yves BONDIAU, radiotherapist and Director of the Mediterranean Institute of Protontherapy. “With this technique, a precise and high dose of proton radiation is delivered to the tumor while preserving the surrounding healthy cells.”

Actualité

INAUGURATION OF THE MEDITERRANEAN INSTITUTE OF PROTONTHERAPY

The Mediterranean Institute of ProtonTherapy of the Center Antoine Lacassagne was inaugurated on Thursday 30 June 2016 by Mr Adolphe Colrat, Prefect of the Alpes-Maritimes, Mr Christian Estrosi, President of the Provence Alpes Côte d’Azur Region and President of the Metropole Nice Côte d’Azur, Mr Eric Ciotti, Member or Parliament and President of the Alpes-Maritimes Department, Mr Philippe Pradal, Mayor of Nice, Mr Paul Castel, General of the Provence Alpes Côte d’Azur Regional Health Agency and Professor Joël Guigay, General Director of the Center Antoine Lacassagne.